Feasibility and impact of laparoscopic sleeve gastrectomy after renal transplantation on comorbidities, graft function and quality of life

Naif A AlEnazi, Khaled S Ahmad, Ilham A Elsamahy, Mohamed S Essa, Naif A AlEnazi, Khaled S Ahmad, Ilham A Elsamahy, Mohamed S Essa

Abstract

Background: The aim of this study is to clarify the feasibility and effect of laparoscopic sleeve gastrectomy (LSG) on comorbidities, graft function and quality of life in patients who underwent renal transplantation (RT).

Methods: This is a retrospective review of five patients who underwent LSG after RT. Demographic data, anthropometric parameters, the effect on comorbidities, postoperative course, immunosuppressive medications, causes of RT, renal function, the survival of graft, and quality of life after SG in obese patients with a history of RT were assessed using BAROS-Moorhead-Ardelt survey RESULTS: From September 2015 to September 2019, 5 renal transplant patients underwent LSG; three female, and two male. Median body mass index (BMI) decreased from 42.17 kg/m2 (range 36-55) before surgery to 28.16 kg/m2 (range 25-42) after surgery. Improvement in blood pressure, triglyceride, and cholesterol levels was observed, and all cases were able to decrease their medications. Insulin was stopped and replaced with linagliptin in all diabetic patients. Graft function improved, and proteinuria level decreased in all cases. All patients reported to have an excellent quality of life.

Conclusion: LSG showed excellent outcomes in this high-risk group of patients regarding comorbidities, graft function and quality of life.

Keywords: Dyslipidemia; Graft function; Hypertension; Renal transplantation; Sleeve gastrectomy.

Conflict of interest statement

There is no conflict of interest to disclose.

Figures

Fig. 1
Fig. 1
%EWL
Fig. 2
Fig. 2
Graft function (creatinine level) before and after LSG

References

    1. Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. SeminNephrol. 2013;33(1):14–22.
    1. Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am SocNephrol. 2006;17(5):1453–1459.
    1. Ejerblad E, Fored CM, Lindblad P, et al. Obesity and risk for chronic renal failure. J Am SocNephrol. 2006;17(6):1695–1702.
    1. Friedman AN, Miskulin DC, Rosenberg IH, et al. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis. 2003;41(2):480–487.
    1. Imes CC, Burke LE. The obesity epidemic: the United States as a cautionary tale for the rest of the world. Curr Epidemiol Rep. 2014;1(2):82–88.
    1. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002;13:S37–40.
    1. MacLaughlin HL, Cook SA, Kariyawasam D, et al. Nonrandomized trial of weight loss with orlistat, nutrition education, diet and exercise in obese patients with CKD: 2-year followup. Am J Kidney Dis. 2010;55(1):69–76.
    1. Kälble T, Lucan M, Nicita G, et al. EAU guidelines on renal transplantation. Eur Urol. 2005;47(2):156–166.
    1. Hasse J. Pretransplant obesity: a weighty issue affecting transplant candidacy and outcomes. Nutr Clin Pract. 2007;22(5):494–504.
    1. Weiss H, Nehoda H, Labeck B, et al. Organ transplantation and obesity: evaluation, risks and benefits of therapeutic strategies. Obes Surg. 2000;10(5):465–469.
    1. Kokot F, Więcek A, Adamczak M, et al. Pathophysiological role of leptin in patients with chronic renal failure, in kidney transplant patients, in patients with essential hypertension, and in pregnant women with preeclampsia. Artific Organs. 1999;23(1):70–74.
    1. Pischon T, Sharma AM. Obesity as a risk factor in renal transplant patients. Nephrol Dial Transpl. 2001;16(1):14–17.
    1. Hakeem AR, Cockbain AJ, Raza SS, et al. Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. Liver Transpl. 2013;19(5):551–562.
    1. Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.
    1. Tichansky DS, Madan AK. Laparoscopic Roux-en-Y gastric bypass is safe and feasible after orthotopic liver transplantation. Obes Surg. 2005;15(10):1481–1486.
    1. Myers JA, Clifford JC, Sarker S, et al. Quality of life after laparoscopic adjustable gastric banding using the Baros and Moorehead-Ardelt Quality of Life Questionnaire II. JSLS J Soc Laparoendosc Surg. 2006;10(4):414.
    1. Rogers CC, Alloway RR, Alexander JW, et al. Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study. Clin Transplant. 2008;22(3):281–291.
    1. Curran SP, Famure O, Li Y, et al. Increased recipient body mass index is associated with acute rejection and other adverse outcomes after kidney transplantation. Transplantation. 2014;97(1):64–70.
    1. Viscido G, Gorodner V, Signorini FJ, et al. Sleeve gastrectomy after renal transplantation. Obes Surg. 2018;28(6):1587–1594.
    1. Lee CM, Cirangle PT, Jossart GH. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc. 2007;21(10):1810–1816.
    1. Leyba JL, Aulestia SN, Llopis SN. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the treatment of morbid obesity. A prospective study of 117 patients. Obes Surg. 2011;21(2):212–216.
    1. Trastulli S, Desiderio J, Guarino S, et al. Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials. Surg Obes Relat Dis. 2013;9(5):816–829.
    1. Khoraki J, Katz MG, Funk LM, Campos GM, et al. Feasibility and outcomes of laparoscopic sleeve gastrectomy after solid organ transplantation. Surg Obes Relat Dis. 2016;12(1):75–83.
    1. Young MT, Gebhart A, Phelan MJ, et al. Use and outcomes of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass: analysis of the American College of Surgeons NSQIP. J Am Coll Surg. 2015;220(5):880–885.
    1. Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons-Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254(3):410.
    1. Jakob T, Cal P, Deluca L, et al. Shorter than 24-h hospital stay for sleeve gastrectomy is safe and feasible. Surg Endosc. 2016;30(12):5596–5600.
    1. Lin MY, Tavakol MM, Sarin A, et al. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis. 2013;9(5):653–658.
    1. Lin MY, Tavakol MM, Sarin A, et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg Endosc. 2013;27(1):81–85.
    1. Alexander JW, Goodman HR, Gersin K, et al. Gastric bypass inmorbidly obese patients with chronic renal failure and kidney transplant. Transplantation. 2004;78(3):469–474.
    1. Golomb I, Winkler J, Ben-Yakov A, et al. Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation. Am J Transplant. 2014;14(10):2384–2390.
    1. Kim Y, Jung AD, Dhar VK, et al. Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients. Am J Transplant. 2018;18(2):410–416.
    1. Navarro-Díaz M, Serra A, Romero R, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol. 2006;17(12 suppl 3):S213–217.
    1. Elli EF, Gonzalez-Heredia R, Sanchez-Johnsen L, et al. Sleeve gastrectomy surgery in obese patients post–organ transplantation. Surg Obes Relat Dis. 2016;12(3):528–534.
    1. Fernández-Fresnedo G, Plaza JJ, Sánchez-Plumed J, et al. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant. 2004;19(3):47–51.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner